Call us 24/7


GI Cancer Center, Tulsa

The Gastrointestinal (GI) Cancer Center at Cancer Treatment Centers of America® (CTCA), Tulsa, provides extensive expertise in the diagnosis and treatment of gastrointestinal malignancies. Our multidisciplinary team of board-certified gastroenterologists, surgical oncologists, radiation oncologists and medical oncologists work together with supportive care providers to deliver quality clinical care with a patient-centered approach. We also offer minimally invasive treatments to help each patient receive comprehensive, up-to-date, personalized treatment. The team strives to maintain quality of life for all patients with gastrointestinal malignancies.

Cancers we treat

Our gastrointestinal team also treats cancers that have metastasized to the GI tract, such as lung and breast cancers, as well as precancerous conditions, such as Barrett’s esophagus.

U.S. News & World Report names CTCA Tulsa high-performing hospital for colon cancer surgery

Each year, U.S. New & World Report evaluates the performance of nearly 4,400 hospitals nationwide in colon cancer surgery using data on patient survival, nurse staffing, volume and more. Hospitals receive one of three ratings: high-performing, average or below-average.

For 2020-21, CTCA Tulsa received the highest possible ranking for colon cancer surgery, named a “high-performing” hospital in this category.

Meet our GI Cancer Center team

The experts who make up the Gastrointestinal Cancer Center at CTCA Tulsa are committed to offering integrative, state-of-the-art treatments for GI cancer patients. Our Gastrointestinal Cancer Program includes board-certified cancer experts, including gastroenterologists who have expertise in treating GI malignancies using advanced and minimally invasive technologies to fight the disease. This team works together, all under one roof, to understand your individual needs and offers comprehensive, personalized treatments while meeting regularly to discuss your progress and modify your treatment accordingly. Explore the links below to learn more about the team.

Medical Director of Gastroenterology and Vice Chief of Staff,  CTCA Tulsa

Scott Hendrickson

Gastroenterologist, Chief of Staff, CTCA Tulsa

Asha Karippot - Medical Oncologist and Hematologist

Asha Karippot

Medical Oncologist and Hematologist, CTCA Tulsa

Medical Director of Surgery and Breast Surgery and Medical Staff Secretary, CTCA Tulsa

Michael Thomas

Medical Director of Surgery and Breast Surgery and Medical Staff Secretary, CTCA Tulsa

Treating your cancer

Using evidence-based medicine, your Gastrointestinal Cancer Center team will develop a unique treatment plan tailored to your specific diagnosis. When you arrive at our hospital, your care team will review your symptoms with you and obtain a health history. Then, we’ll use advanced diagnostic tools and interventional procedures to evaluate the tumor(s). We are dedicated to providing a diagnosis and treatment plan within days of your arrival to the facility. After you are diagnosed, we work with you to identify treatments tailored to your specific needs. Your treatment plan may include surgery, interventional gastroenterology procedures, chemotherapy, radiation or another appropriate therapy, or a combination of two or more of these.

Treatment advances

We provide a wide range of treatment options for GI cancers. The team uses advanced technologies to examine the GI tract more thoroughly, usually with minimally invasive procedures. We may recommend innovative techniques, such as ablative treatments, to help relieve obstructions in the GI tract and pain caused by tumors. Some procedure options include:

Biliary radiofrequency ablation (RFA): In this procedure, a radiologist uses an electric current to destroy cancer cells. RFA is often used as a palliative procedure to clear obstructed stents and remove tumors that may be causing pain. This treatment may be an option for patients who are not candidates for chemotherapy or surgery and whose disease has progressed while on chemotherapy.

Celiac plexus neurolysis: For pancreatic cancer patients, we may perform therapeutic endoscopic ultrasound (EUS) to relieve pain.

Cryotherapy or esophageal stents: These options may be used to treat patients having difficulty with swallowing caused by esophageal tumors.

Fiducial marker placement: Fiducial markers are placed inside a tumor using minimally invasive endoscopic ultrasound before radiation therapy. Using these markers allows for more precise targeting of tumors and helps reduce harm to healthy tissue.

Photodynamic therapy: This innovative treatment uses light-activated drugs and a light source to kill cancer cells. This treatment option may be used for multiple types of GI and other cancers, such as lung cancer.

Small bowel enteroscopy: This minimally invasive option allows doctors to navigate the small intestine and perform diagnostic or treatment procedures.

Integrative cancer care

Throughout your treatment, your gastrointestinal cancer care team will use multiple measures to help anticipate, manage and, when possible avoid cancer-related side effects and improve your quality of life. Since cancers of the GI tract impact the digestive system, patients work closely with a dietitian throughout their treatment to provide nutritional support. In addition, GI cancer patients may also meet with additional supportive care experts, including a pain management physician, speech, physical or occupational therapist, mind-body therapist, sexual wellness therapist and spiritual support provider.

"CTCA truly cared about my patient experience, treating my whole person and actively monitoring my quality of life. Any issues were quickly addressed, and I had access to a variety of supportive care therapies."

Job L

Job L.

Esophageal Cancer


More About JOB

GI cancer clinical trials

Our team of gastroenterologists conducts clinical trials as part of the CTCA commitment to providing new and innovative treatment options when possible. As part of this commitment, we may offer clinical trials to patients with GI cancers who meet certain criteria. These trials study potential advancements in treatment approaches, which may include targeted therapy, immunotherapy, offering some qualifying patients options that may not otherwise have been available to them.

Learn more about the CTCA clinical trials program and which trials are available

Where we are located

CTCA Tulsa

Gastrointestinal Cancer Center
10109 E. 79th St.
Tulsa, OK 74133

New Patients: 855-641-5086
Existing Patients: (918) 800-CTCA

Get directions